Sword & Shield Pharma has informed that it has enclosed confirmation certificate received from MCS Share Transfer Agent, Registrar and Share Transfer Agent (RTA) as per Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2019.
The above information is a part of company’s filings submitted to BSE.